R Squared’s Medpace MEDP Stock Holding History

R Squared’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-660	Closed	-$371K	–	596
2025 Q4	$371K	Buy	+660	New	+$375K	0.17%	181
2025 Q1	–	Sell	-90	Closed	-$29.9K	–	987
2024 Q4	$29.9K	Buy	+90	New	+$30.5K	0.03%	705

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

R Squared's MEDP Position: Q1 2026 in Review

R Squared sold out of Medpace (MEDP) in Q1 2026, closing a stake of 660 shares — an estimated $371K sold.

R Squared first reported a position in MEDP in Q4 2024 and held it in 2 quarters. The position peaked at $371K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

R Squared reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
R Squared sold 660 Medpace shares in Q1 2026, an estimated $371K.
R Squared first reported a position in Medpace in Q4 2024 and held it in 2 quarters.
R Squared's Medpace position peaked at $371K in Q4 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.